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Purpose. To characterize volume-based care of uterine cancer among women aged ≤50 years. Methods. The Maryland Health
Service Cost Review Commission database was accessed for uterine cancer surgical cases from 1994 to 2005. Cross-tabulations
and logistic regression models were used to evaluate for signiﬁcant associations among volume-based care and other variables
comparing women ≤50 years with those aged >50 years. Results.W o m e n≤50 years comprised 13.6% of the cases. Women ≤50
years were less likely to be managed by high-volume surgeons (31.6% versus 35.1%, P = 0.02). For women ≤50 years, there was
a trend toward management at low-volume hospitals (52.0% versus 54.0%, P = 0.22). No deaths were reported among the group
of women ≤50 years treated by high-volume providers or at high-volume centers. Women ≤50 years managed by high-volume
surgeons had longer length of stay (P<0.001) and higher adjusted cost of hospital-related care (P<0.00). Women ≤50 years
managed at high-volume centers had higher adjusted cost of hospital-related care (P = 0.01). Conclusion. Primary surgical care of
young women with uterine cancer is often performed by low-volume providers.
1.Introduction
Uterine cancer is the most common diagnosed gynecologic
cancer among women in the United States [1], with 43,470
estimated new cases and approximately 7,950 estimated
deaths in 2010 [2]. Although uterine cancer is found mainly
in the older patient population, up to 14% of uterine cancers
are found in women younger than 45 years of age [3]. Most
studies have demonstrated that younger women have a
lower risk of death from uterine cancer than older women
independent of stage at diagnosis [4, 5]. Surgical manage-
ment of uterine cancer entails a staging procedure which
includes a total hysterectomy, salpingooophorectomy, and
possible lymph node dissection depending on the spread of
the disease and histological type.
Postmenopausal and abnormal premenopausal bleeding
are the primary symptoms of uterine cancer. A high index
of suspicion must be maintained if the diagnosis of uterine
canceristobemadeintheyoungpatient.Youngwomenwith
or without risk factors may present with abnormalities in
their menstrual periods, which can be initially treated with
hormonal therapy, thereby delaying the diagnosis of cancer.
Some risk factors for uterine malignancy include prolonged
exposure to unopposed estrogen either endogenous, (e.g.,
early menarche, late menopause, nulliparity, polycystic ovar-
ian syndrome, obesity), or exogenous (e.g., estrogen therapy
or hormone replacement without progesterone) [3]. Other
independent risk factors include diabetes and hypertension
[3]. Uterine cancer in young women is often associated with
early-stage disease, well-diﬀerentiated tumors, and a good
prognosis [6–8].
The actual care delivered to women diagnosed with
uterine cancer appears to depend upon a number of vari-
ables including surgeon training, hospital volume, extent of
disease, patient characteristics, and physician access. These
women are mostly managed by gynecologic oncologists as
well as by nongynecologic oncologists (general gynecologists
and general surgeons). Gynecologic oncologists are speciﬁ-
cally trained to perform the required staging and cytoreduc-
tivesurgicalproceduresforuterinecancer.However,patterns2 ISRN Surgery
of care studies have shown that gynecologic oncologists
provided care in 48.8% of the patients and gynecologists in
50.2% of the cases [9]. General surgeons assisted gynecolo-
gists in 36.5% of cases [9]. Roland et al. [9] have shown that
the gynecologic oncologist completed the surgical staging
two times more frequently than the general gynecologist
(94.0%versus45.2%,P<0.05).Theyconcludedthatwomen
with uterine cancer managed by gynecologic oncologists
are more likely to receive comprehensive surgical staging
resulting in an eﬃcient use of health care resources and
minimizing the potential morbidity associated with adjuvant
radiation therapy [9].
Numerous studies have evaluated the association of
surgeon case volume with clinical outcomes for various
procedures and have shown that higher surgeon volume is
associated with improved outcomes [10–13]. While specialty
training is critically important to quality cancer care, recent
attention has also focused on the positive relationship
between surgeon and hospital case volume and clinical
outcomes for malignancies treated with technically complex
surgical procedures [14]. Recently, there has been an interest
in elucidating patterns of care for patients treated with
uterine cancer. Most studies evaluating age-based outcomes
for uterine cancer have been single institution analysis con-
taining only a small portion of patients. Age-based analysis
of resource allocation has not been performed for younger
patients. More speciﬁcally, prior studies have not evaluated
whether care provided by high-volume surgeons at high-
volumecentersleadstodiﬀerencesinresourceallocationand
short-term survival among younger patients. Therefore, the
goals of this study were to evaluate volume-based care for
women with uterine cancer aged 50 years and younger using
a statewide population database.
2. Methods
Approval to conduct this study was obtained from the Johns
Hopkins Medical Institutions Clinical Research Committee
and Joint Committee on Clinical Investigation, and the
requirements for informed patient consent were waived.
The study design was a cross-sectional analysis of hospital
discharge data from the nonfederal acute care hospitals in
Maryland collected by the Maryland Health Services Cost
Review Committee (HSCRC). The HSCRC database pro-
vides information regarding the index hospital admissions
and is limited to 30 days of followup. The main study
objective was to characterize volume-based care among
women ≤50 years when compared to women >50 years. A
subgroup analysis among women ≤50 years with regards to
surgeon and hospital uterine cancer volume was performed
to evaluate the risk of in-hospital related death and associa-
tions with the length of hospital stay, hospital-related costs,
and ICU length of stay.
All adult female patients, 18 years of age and older, who
underwent a surgical procedure including a hysterectomy for
a malignant uterine neoplasm in Maryland between January
1, 1994 until December 31, 2005 were included in the study.
The International Classiﬁcation of Disease, 9th revision
Table 1: Demographic characteristics among women of diﬀer-







Number of patients 844 (13.6) 5337 (86.4)
Ethnic classiﬁcation
White 658 (78.0) 4205 (78.7)
African-American 125 (14.8) 937 (17.6)
American-Indian or Eskimo 34 (4.0) 132 (2.5)
Asian or Paciﬁc Islander 23 (2.7) 42 (0.8)
Unknown 4 (0.5) 21 (0.4)
Insurance payer
Medicaid/Medicare 67 (7.9) 2854 (53.5)
Commercial 156 (18.5) 478 (8.9)
HMO 340 (40.3) 1023 (19.2)
Blue Cross 248 (29.4) 833 (15.6)
Other 33 (3.9) 149 (2.8)
Hospital type
Community 569 (67.4) 3532 (66.2)
Community teaching 179 (21.2) 1271 (23.8)
University 96 (11.4) 534 (10.0)
Hospital volume
Low volumea 405 (48.0) 2441 (46.0)
High volumeb 439 (52.0) 2896 (54.0)
Surgeon volume
Low volumec 562 (66.6) 3296 (61.8)
High volumed 267 (31.6) 1874 (35.1)
Unknown 15 (1.8) 167 (3.1)
Attending physician or operating
surgeon concordance
Concordance 761 (90.2) 4622 (86.6)
Discordance 66 (7.8) 538 (10.1)
Unknown 17 (2.0) 177 (3.3)
a<200cases/study period.
b ≥200 cases/study period.
c <100 cases/study period.
d ≥100 cases/study period.
(ICD-9) code 182.0 (malignant uterine neoplasm) was used
for sorting. All histologic types of uterine cancer were
included in the search. The surgical procedures included in
theanalysiswerelimitedtothoseincorporatinghysterectomy
as this was felt to be the most likely to capture those patients
undergoing initial surgery for uterine cancer.
The main independent variable was patients’ age. Patient
age was modeled as a categorical variable (patients 50 years
of age and younger compared to patients over 50 years of
age). This age cutoﬀ was designated based on the average age
of menopause as 51.4 years [15, 16]. Frequency distribution
for variables like ethnicity, insurance payer status, hospital
volume, surgeon volume, hospital type, inpatient death,
and concordance between attending and operating physicianISRN Surgery 3
Table 2: Variables inﬂuencing age among women treated by primary surgery for uterine cancer in the state of Maryland, 1994–2005.
Covariate ≤50 years, median (range) >50 years, median (range) P value
Total adjusted cost $6,160 ($520–185,342) $6,587 ($0–422,661) 0.0002
ICU Daysa 0 (0–28) 0 (0–103) 0.0800
Length of stay (days) 3 (0–46) 3 (0–126) <0.0001
aIntensive Care Unit.
Table 3: Variables inﬂuencing surgeon volume among women aged ≤50 years in the state of Maryland during 1994–2005.
Covariate Low-volume surgeon, median (range) High-volume surgeon, median (range) P value
Total adjusted cost $5,374 ($520–120,461) $7,724 ($1598–185,342) <0.0001
ICU Daysa 0 (0–5) 0 (0–28) 0.2900
Length of stay (days) 3 (0–42) 3 (1–46) 0.0030
aIntensive Care Unit.
was tabulated among the two groups. Information regard-
ing International Federation of Gynecology and Obstetrics
(FIGO) or American Joint Committee on Cancer (AJCC)
stage of disease, tumor grade, histological subtype, extent of
disease,orresidualdiseasewasnotavailablefromtheHSCRC
database. In addition, the HSCRC database only provides
clinical information for the index hospital admission, so that
data on clinical outcomes beyond this time period could
not be assessed. Both surgeon and hospital volume were
modeled as categorical variables. Based on previous research
in volume-based care in uterine cancer, surgeons performing
≥100 cases of uterine cancer per study period were catego-
rized as high volume, and those performing <100 cases of
uterinecancerperstudyperiodaslowvolume[17].Surgeons
were included in the analysis if they performed at least one
uterine cancer surgery during the entire study period. Based
on previous research in volume-based care in uterine cancer,
hospitals with ≥200 cases of uterine cancer per study period
were categorized as high volume, while those with <200
cases of uterine cancer per study period were categorized as
low volume [17]. Similarly, hospitals were included in the
analysis if at least one uterine cancer surgery was performed
during the entire study period. A community teaching
hospital was deﬁned as a nonuniversity hospital with a
residency program in Obstetrics and Gynecology. Hospital-
related charges for each index admission were converted to
the organizational cost of providing care using cost to charge
ratios for individual hospitals. Cost to charge ratios were
calculated from data from the Health Services Cost Review
Commission by dividing the average inpatient expense
by the average inpatient revenue of each hospital during
each year of the study interval [18]. This ratio was then
multiplied by each patients’ charge to obtain the cost per
admission [19]. All costs were converted to 2005 USD [20].
Cross-tabulations were analyzed using chi-square tests.
T-test for simple linear regression was employed to evaluate
adjusted cost of hospital-related care, intensive care unit
length of stay, and admission length of stay among the two
age groups. T-test for simple linear regression was done for
the subset group of women aged 50 years and younger to
evaluate the variables of adjusted cost of hospital-related
care, admission length of stay, and intensive care unit length
of stay among hospital’s and surgeon’s volume. All statistical
computations were performed using the SAS system [21],
and all reported P values are two sided.
3. Results
A total of 6,181 women who met the criteria for a primary
surgical procedure for a malignant uterine neoplasm were
identiﬁed in the state of Maryland during the period of
1994–2005. Women aged 50 years and younger comprised
13.6% (n = 844) of the cases. Most of the women aged
50 years and younger were white (78.0%), had insurance
coverage through an HMO (40.3%), and were treated in a
community-based hospital (67.4%) (Table 1). Young women
were more likely than older women to have concordance
between the operating physician and the attending physician
(P = 0.03) (Table 1). In other words, young women were
more likely to have an operating surgeon that was the same
clinician of record. Younger women were more likely to
have shorter length of hospitalization stay (P<0.0001) and
lower adjusted cost of hospital-related care (P = 0.0002).
There were no signiﬁcant diﬀerences between the lengths
of intensive care stay between groups (Table 2). Overall, 85
deaths were reported during the immediate 30-day period.
Four of the reported deaths occur among the group of
women 50 years of age and younger. Information regarding
the cause of death was not available from the database.
In total, 894 diﬀerent surgeons provided primary uterine
cancer surgical care, although not all surgeons provided
continuous care for the entire duration of the study period.
Only 9 (1.0%) of the surgeons were categorized as high-
volume surgeons. Women aged 50 years and younger were
less likely to be managed by high-volume surgeons when
compared to women older than 50 years (31.6% versus
35.1%, resp., P = 0.02). In the subgroup of women aged 50
years and younger, those that were managed by high-volume
surgeonsweremorelikelytohavelongerhospitalizationstays
(P = 0.003) and higher adjusted cost of hospital-related
care (P<0.0001) (Table 3). No diﬀerence was observed
in terms of ICU length of stay between high- and low-
volume surgeons. No deaths were reported among high-
volume surgeons during the immediate 30-day period. Due4 ISRN Surgery
Table 4: Variables inﬂuencing hospital volume among women aged ≤50 years in the state of Maryland during 1994–2005.
Covariate Low-volume hospital, median (range) High-volume hospital, median (range) P value
Total adjusted cost $5,663 ($1,455–46,702) $6,560 ($520–8,450) 0.0100
ICU Daysa 0 (0–5) 0 (0–28) 0.6000
Length of stay (days) 3 (0–42) 3 (0–46) 0.5400
aIntensive Care Unit.
to the lack of events on one of the groups, a statistical
comparison of death rates between high- and low-volume
surgeons could not be performed.
A total of 49 hospitals provided care for uterine cancer
patients during the study period. Only 8 (16.3%) hospitals
meet the criteria of high-volume hospitals. No diﬀerence was
observed among groups in terms of access to high-volume
centers (52.0% versus 54.0%, P = 0.22). In the subgroup
of women 50 years of age and younger, those admitted
to a high-volume hospital were more likely to have higher
adjusted cost of hospital-related care (P = 0.01) (Table 4).
No diﬀerence was observed among hospital and ICU length
of stay among groups. No deaths were reported among high-
volume hospitals during the immediate 30-day period. Due
to the lack of events on one of the groups, a statistical
comparison of death rates between high- and low-volume
surgeons could not be performed.
4. Discussion
Approximately 14% of uterine cancers develop among
women that are younger than 45 years [3]. Several studies
have demonstrated that age is an independent predictor of
overall survival [4, 5]. Our analysis of the HSCRC database
from 1994–2005 conﬁrms that younger women have lower
short-term mortality than older women diagnosed with
uterine cancer. The fact that younger women have better
outcomes can be explained by a number of hypotheses. It
may be that younger individuals have a better health proﬁle,
with less morbidity and concurrent medical problems.
Younger body/tissues may respond to a surgical insult with
less postoperative complications and accelerated healing.
Also, uterine cancer in young women is often associated with
early-stage disease, well-diﬀerentiated tumors, and a good
prognosis[6–8].Eventhoughthelackofeventsdidnotallow
performingastatisticalanalysis,noin-hospitalrelateddeaths
were reported among the young group of women treated by
high-volume surgeons or at high-volume centers.
In addition to reduced mortality, lengths of hospital
stay and hospital costs for younger women with uterine
cancerwerelower.Thereducedrateofmedicalcomorbidities
at baseline in younger women likely contributed to this
diﬀerence as preoperative comorbidities are an independent
predictor of length of postoperative hospitalization and
therefore cost [22]. Younger women were more likely to
be managed at university-based hospitals and more likely
to have an operating surgeon that was the same attending
physician of record decreasing the opportunity for mis-
communication and repetition of testing that could occur
when multiple providers are involved in patient care. Rogers
and Curtis [23] had shown that continuity of care leads
to decreased hospital admissions, decreased length of stay,
reduced duplication of diagnostic testing, increased patient
satisfaction, and improved compliance. The high level of
concordance in the younger women may account for the
improved outcomes such as the decreased cost and shorter
length of stay.
Theanalysissuggeststhatyoungerwomenwerelesslikely
to be managed by high-volume surgeons. For women ≤50
years, there was a trend toward management at low-volume
centers. A perceived lower risk of cancer risk or mortality,
limited ﬁnancial resources, unwillingness to travel long
distances for care, and the absence of medical comorbidities
may lead fewer younger women to seek out the expertise of
a high-volume specialist on their own. Several studies have
shown the beneﬁt of women that have been cared for by
a gynecologic oncologist [9, 24, 25]. Although the overall
peri-operative outcomes were similar, the subspecialists were
more likely to perform comprehensive surgical staging, if
necessary, and the patient was less likely to receive adjuvant
radiotherapy. The overall survival favored those patients
managed by the general gynecologist, with no diﬀerence in
disease-free interval. This may reﬂect the patient population
that is usually managed by the general gynecologist, as
compared to the gynecologic oncologist.
Similartothediﬀerencesincostsofcarebetweenyounger
and older women, younger women treated at low-volume
settings had lower costs of care and shorter hospital stays.
The reduced rate of medical comorbidities of women treated
atthesesettingsislikelytocontributetothesecostdiﬀerences
for the same reasons as mentioned previously. The HSCRC
database cannot be queried to clarify whether high-volume
surgeons are located exclusively at high-volume hospitals;
therefore it is unclear whether higher costs are impacted by
more frequent care by gynecologic oncologists. Low-volume
hospital costs may also be reduced due to the diﬀerent
resources of these facilities. Surgeons may be less inclined to
perform aggressive procedures if these low-volume facilities
do not have adequate support (i.e., access to consultants
or high-acuity ICU care) and thus refer complex patients
to high-volume centers. Improved eﬃciency at low-volume
hospitals cannot be excluded as an alternative cause forlower
costs.
The strength of this study lays in the relatively large
number of patients included form institutions across the
state of Maryland. Unfortunately, the Maryland HSCRCISRN Surgery 5
database is limited in ways typical of large population-based
s t u d i e sa si td o e sn o tp r o v i d ef o l l o w u pb e y o n d3 0d a y sf r o m
the index admission and contains no information on either
AJCC or FIGO stage of disease, tumor grade, or histological
subtype. Given these restrictions, a meaningful analysis of
long-term surgical outcome was not practical from the
available data. Also, the HSCRC does not provide infor-
mation in terms of performance status, ASA scores, and
comorbidities. These factors may have had an impact on
the overall morbidity and mortality between the two pop-
ulations studied. Furthermore, additional information re-
garding the baseline medical condition of the populations
was not examined, and this could be a confounding factor
ontheresults.Asecondlimitationisthatthereisapossibility
that the grouping by case volume could be too selective and
there could be subgroups in the lower-volume level that
still are able to achieve excellent outcomes. Due to the lack
of previous reports of case volume among uterine cancer,
a third limitation of the current study is that our selected
volume criteria have not been widely validated as outcomes
measures.
Despite these limitations, the current study provides
the most extensive evaluation on volume-based care among
young women that underwent surgery for uterine cancer.
The information obtained in this study increases our current
knowledge of volume-based care of young women diagnosed
withuterinecancerandmaybeusefulindeveloping strategic
planning in order to improve the care oﬀered to this pop-
ulation.
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